J Korean Ophthalmol Soc.  2000 Feb;41(2):459-468.

Comparison of the Intraocular Pressure Reducing E ffect of Latanoprost with Timolol

Affiliations
  • 1The Institute of Vision Research, College of Medicine, Yonsei University, Seoul, Korea.
  • 2Department of Ophthalmology, Yonsei University College of Medicine.
  • 3Department of Ophthalmology, College of Medicine, Hanlim University, Sac.

Abstract

We compared the intraocular pressure reducing effect and side effects of 0.005%Latanoprost administered once daily with 0.5%Timolol administered twice daily in patients with open-angle glaucoma or ocular hypertension. This was an open randomized study with two parallel groups and a treatment period of 12 weeks. A total of 76 patients were included:38 in the Latanoprost group and 38 in the Timolol group. Intraocular pressure was reduced from 25.92 mms of mercury to 17.12 mms of mercury[33.91%]with Latanoprost and from 22.53 mms of mercury to 18.38 mms of mercury[18.42%]with Timolol. The efficacy of Latanoprost was statistically superior to timolol[p<0.001]. Latanoprost induced a slight conjunctival hyperemia and ocular discomfort but both drugs were generally well tolerated. Iris hyperpigmentation reported as a significant side effect of Latanoprost was not observed during 12 weeks of follow-up. It is concluded that Latanoprost administered once daily in the evening reduced intraocular pressure as well as and probably more than Timolol administered twice daily.

Keyword

Glaucoma; Intraocular pressure; Latanoprost; Timolol

MeSH Terms

Follow-Up Studies
Glaucoma
Glaucoma, Open-Angle
Humans
Hyperemia
Hyperpigmentation
Intraocular Pressure*
Iris
Ocular Hypertension
Timolol*
Timolol
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr